Skip to main content

Duke Medical Center to Use Wafergen System in Genotyping Studies

NEW YORK (GenomeWeb News) – Duke University Medical Center researchers will use WaferGen's real-time PCR system to conduct genotyping studies aimed at discovering genetic variants linked to breast cancer, the company said today.

Under the agreement, scientists in the Institute for Genome Sciences and Policy will conduct genotyping studies with the SmartChip Real-Time PCR system to validate nucleotide polymorphisms associated with breast cancer, and will study the impact those variants have on disease prognosis and response to treatment.

WaferGen said that this is the first time its system has been used for genotyping studies to validate SNPs.

The firm's Chairman and CEO, Alnoor Shivji, said in a statement that cancer genetics "is a therapeutic area that is of significant interest to WaferGen, as evidenced by the proprietary oncology gene panel assays that we have already developed for use with the SmartChip system."

Financial terms of the agreement were not released.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.